| Pharmaceutical active ingredients: |
| Ergoloid Mesylates |
| Available forms, composition and doses of Ergotox: |
| Capsules, Retard; Oral; Ergoloid Mesylates 2.5 mg |
| Ergotox medical category: |
| Human:Sympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE01 - Ergoloid Mesylates |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| CT-Arzneimittel |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ergotina | Dihydroergocristine Mesylate | Istituto Chimico Internazionale Dr. Giuseppe Rende |
| Ergoton-A | Ergotamine Succinate | Unidentified Pharmaceutical Company |
| Ergotonin | Dihydroergotamine Mesylate | G. Streuli |
| Ergotonine | Dihydroergotamine Mesylate | G. Streuli |
| Ergotop | Nicergoline | IVAX; F. Joh. Kwizda; Horna Business Service; Medico Uno |
| Ergotrate | Ergonovine Maleate | Eli Lilly; Armstrong Laboratorios de Mexico |
| Ergotyl | Methylergonovine Maleate | R.X. Company |
| Ergovasan | Dihydroergotamine Mesylate | Fujisawa; Klinge Pharma |
| Ergovasan Retard | Dihydroergotamine Mesylate | Fujisawa; Klinge Pharma |
| Ergovis | Nutritional Supplement | Bonomelli Divisione Farmacia |